Valuation : Inogen, Inc.

Market Cap 141M 122M 115M 104M 195M 13.46B 197M 1.37B 525M 6.79B 529M 518M 21.62B P/E 2026 *
-6.94x
P/E 2027 * -11.2x
Enterprise Value 141M 122M 115M 104M 195M 13.46B 197M 1.37B 525M 6.79B 529M 518M 21.62B EV / Sales 2026 *
0.4x
EV / Sales 2027 * 0.38x
Free-Float
87.05%
Yield 2026 *
-
Yield 2027 * -
1 day+2.51%
1 week-2.03%
Current month-1.12%
1 month-8.61%
3 months-17.03%
6 months-12.95%
Current year-20.98%
1 week 5.16
Extreme 5.155
5.54
1 month 5.16
Extreme 5.155
5.82
Current year 5.16
Extreme 5.155
7.67
1 year 5.16
Extreme 5.155
9.13
3 years 4.13
Extreme 4.13
13.33
5 years 4.13
Extreme 4.13
50.21
10 years 4.13
Extreme 4.13
287.79
Manager TitleAgeSince
Chief Executive Officer 55 10/11/2023
Director of Finance/CFO 48 06/04/2026
Chief Operating Officer 56 06/07/2026
Director TitleAgeSince
Director/Board Member 66 06/08/2014
Chairman 65 29/12/2021
Director/Board Member 59 22/03/2022
Date Insider Type Main position Quantity % Market Cap. Importance
1/9/26 Free

Controller/Auditor

1,500 0.0057%
1/9/26 Free

General Counsel

46,443 0.1750%
1/9/26 Free

Chief Executive Officer

1,500 0.0057%
Change 5-day change 1-year change 3-year change Capi.($)
+2.51%-2.03%-37.82%-10.00% 141M
-1.36%-5.89%-23.76%-0.44% 176B
-0.72%-3.41%-3.26%+12.32% 116B
+0.19%-2.83%+6.30%+80.17% 61.36B
-1.92%-6.01%+7.05%+38.44% 49.42B
+0.81%-3.73%-4.81%-32.56% 48.44B
-1.75%-5.54%+8.93%-20.82% 31.33B
+0.43%-11.10% - - 28.54B
+0.58%+1.84%+36.58%-12.08% 24.37B
+0.49%-7.65%-13.30%+3.79% 21.57B
Average -0.07%-4.78%-2.68%+6.54% 55.79B
Weighted average by Cap. -0.69%-4.90%-6.03%+10.83%

Financials

2026 *2027 *
Net sales 356M 307M 291M 264M 494M 34.05B 498M 3.45B 1.33B 17.17B 1.34B 1.31B 54.67B 373M 321M 304M 276M 517M 35.6B 520M 3.61B 1.39B 17.95B 1.4B 1.37B 57.16B
Net income -20.8M -17.94M -16.96M -15.38M -28.84M -1.99B -29.04M -202M -77.45M -1B -78.08M -76.39M -3.19B -13.35M -11.51M -10.89M -9.87M -18.51M -1.28B -18.64M -129M -49.71M -643M -50.12M -49.03M -2.05B
Net Debt - -
Logo Inogen, Inc.
Inogen, Inc. is a global medical technology company offering respiratory products for use in the homecare setting. The Company partners with patients, prescribers, home medical equipment providers, and distributors to make its respiratory therapy products available. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators (POCs), used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. It also distributes the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure (CPAP) masks in the United States. Its proprietary Inogen One and Inogen Rove POC systems concentrate the air around the patient to offer a source of supplemental oxygen 24 hours a day, seven days a week with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available.
Employees
753
Date Price Change Volume
11/09/26 USD 5.310 +2.51% 248,977
10/09/26 USD 5.180 -1.71% 243,426
09/09/26 USD 5.270 +0.76% 203,759
08/09/26 USD 5.230 -3.51% 316,466
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
5.310USD
Average target price
12.00USD
Spread / Average Target
+125.99%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. INGN Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!